References
Lapecorella M, Mariani G (2008) Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia 14:1170–1175
Perry DJ (2002) Factor VII deficiency. Br J Haematol 118:689–700
Tana M, Tana C, Amerio P, Vitullo G, Di Giosia P, Di Febbo C, Davì G (2015) Severe non-traumatic bleeding, the answer is not in the blood. Intern Emerg Med 10(4):461–464
Giansily-Blaizot M, Verdier R, Biron-Andréani C (2004) Study group of FVII deficiency. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica 89:704–709
Girolami A, Berti de Marinis G, Bertozzi I, Peroni E, Tasinato V, Lombardi AM (2013) Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency. Eur J Haematol 91:152–156
Peyvandi F, di Michele D, Bolton-Maggs PH et al (2012) Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 10(9):1938–1943
Davidson SJ, Turner N, Tillyer L (2010) Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency. Blood Coagul Fibrinolysis 21:707–708
Baltodano LE, Mungall DR, Watson DD (1998) Management of a patient with atrial fibrillation and factor VII deficiency. Ann Pharmacother 32:1251–1252
Arellano-Rodrigo E, Gironella M, Nicolau I, Vila M (2009) Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases. Thromb Haemost 101:402–404
Paulus E, Komperda K, Park G, Fusco J (2016) Anticoagulation therapy considerations in factor VII deficiency. Drug Saf -Case Rep 3:8
Arletti L, Coluccio V, Romagnoli E, Luppi M, Marietta M (2019) Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency. Eur J Haematol 103:67–69
Prisco D, Ageno W, Becattini C, D'Angelo A, Davì G, De Cristofaro R, Dentali F, Di Minno G, Falanga A, Gussoni G, Masotti L, Palareti G, Pignatelli P, Santi RM, Santilli F, Silingardi M, Tufano A, Violi F (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 12(3):387–406
Prisco D (2018) A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management. Intern Emerg Med 13(7):985–988
Marongiu F, Barcellona D (2018) Direct oral anticoagulants: what can we learn? Intern Emerg Med 13(7):989–992
Paul B, Oxeley A, Brigham K, Cox T, Hamilton PJ (1987) Factor II, VII, IX, and X concentrations in patients receiving long term warfarin. J Clin Pathol 40:94–98
Acknowledgements
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors state that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with animals performed by any of the authors. All procedures performed were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As the case report is retrospective, discussion in the Ethics Committee was waived.
Informed consent
Informed consent was obtained from the patient included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pomero, F., Spadafora, L., D’Agnano, S. et al. Direct oral anticoagulants in factor VII deficiency patient. Intern Emerg Med 14, 1353–1356 (2019). https://doi.org/10.1007/s11739-019-02186-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02186-1